163 related articles for article (PubMed ID: 16327152)
1. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
Kim DS; Kim SY; Park SH; Choi YG; Kwon SB; Kim MK; Na JI; Youn SW; Park KC
Biol Pharm Bull; 2005 Dec; 28(12):2216-9. PubMed ID: 16327152
[TBL] [Abstract][Full Text] [Related]
2. Hypopigmentary effects of 4-n-butylresorcinol and resveratrol in combination.
Kim SY; Park KC; Kwon SB; Kim DS
Pharmazie; 2012 Jun; 67(6):542-6. PubMed ID: 22822544
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production.
Kim DS; Park SH; Kwon SB; Li K; Youn SW; Park KC
Arch Pharm Res; 2004 Mar; 27(3):334-9. PubMed ID: 15089040
[TBL] [Abstract][Full Text] [Related]
4. The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.
Kim DS; Lee S; Lee HK; Park SH; Ryoo IJ; Yoo ID; Kwon SB; Baek KJ; Na JI; Park KC
J Pharm Pharmacol; 2008 Mar; 60(3):343-8. PubMed ID: 18284814
[TBL] [Abstract][Full Text] [Related]
5. Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways.
Shin JS; Cho JH; Lee H; Jeong HS; Kim MK; Yun HY; Kwon NS; Kim DS
Biomed Pharmacother; 2017 Aug; 92():122-127. PubMed ID: 28535415
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of melanosomal proteins after hinokitiol treatment.
Choi YG; Bae EJ; Kim DS; Park SH; Kwon SB; Na JI; Park KC
J Dermatol Sci; 2006 Sep; 43(3):181-8. PubMed ID: 16781122
[TBL] [Abstract][Full Text] [Related]
7. Terrein: a new melanogenesis inhibitor and its mechanism.
Park SH; Kim DS; Kim WG; Ryoo IJ; Lee DH; Huh CH; Youn SW; Yoo ID; Park KC
Cell Mol Life Sci; 2004 Nov; 61(22):2878-85. PubMed ID: 15558216
[TBL] [Abstract][Full Text] [Related]
8. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
[TBL] [Abstract][Full Text] [Related]
9. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
[TBL] [Abstract][Full Text] [Related]
10. Baicalin-induced Akt activation decreases melanogenesis through downregulation of microphthalmia-associated transcription factor and tyrosinase.
Jeong HS; Gu GE; Jo AR; Bang JS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Eur J Pharmacol; 2015 Aug; 761():19-27. PubMed ID: 25934572
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of N,N,N-trimethyl phytosphingosine-iodide on melanogenesis via ERK activation-mediated MITF degradation.
Lee WJ; Bang S; Chung BY; Jung H; Oh ES; Chang SE
Biosci Biotechnol Biochem; 2016; 80(1):121-7. PubMed ID: 26263195
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation.
Kim DS; Hwang ES; Lee JE; Kim SY; Kwon SB; Park KC
J Cell Sci; 2003 May; 116(Pt 9):1699-706. PubMed ID: 12665551
[TBL] [Abstract][Full Text] [Related]
13. Hypopigmentary action of dihydropyranocoumarin D2, a decursin derivative, as a MITF-degrading agent.
Kim DS; Park SH; Lee HK; Choo SJ; Lee JH; Song GY; Yoo ID; Kwon SB; Na JI; Park KC
J Nat Prod; 2010 May; 73(5):797-800. PubMed ID: 20392068
[TBL] [Abstract][Full Text] [Related]
14. Menadione (Vitamin K3) decreases melanin synthesis through ERK activation in Mel-Ab cells.
Kim EH; Kim MK; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Eur J Pharmacol; 2013 Oct; 718(1-3):299-304. PubMed ID: 24012927
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranylacetone inhibits melanin synthesis via ERK activation in Mel-Ab cells.
Kim EH; Jeong HS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Life Sci; 2013 Aug; 93(5-6):226-32. PubMed ID: 23792203
[TBL] [Abstract][Full Text] [Related]
16. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes.
Kim DS; Park SH; Kwon SB; Park ES; Huh CH; Youn SW; Park KC
Pigment Cell Res; 2006 Apr; 19(2):146-53. PubMed ID: 16524430
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
Kim DS; Park SH; Park KC
Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
[TBL] [Abstract][Full Text] [Related]
18. Baicalein inhibits melanogenesis through activation of the ERK signaling pathway.
Li X; Guo L; Sun Y; Zhou J; Gu Y; Li Y
Int J Mol Med; 2010 Jun; 25(6):923-7. PubMed ID: 20428797
[TBL] [Abstract][Full Text] [Related]
19. N-(4-methoxyphenyl) caffeamide-induced melanogenesis inhibition mechanisms.
Kuo YH; Chen CC; Wu PY; Wu CS; Sung PJ; Lin CY; Chiang HM
BMC Complement Altern Med; 2017 Jan; 17(1):71. PubMed ID: 28114924
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells.
Jian D; Jiang D; Su J; Chen W; Hu X; Kuang Y; Xie H; Li J; Chen X
Steroids; 2011 Nov; 76(12):1297-304. PubMed ID: 21745488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
